Your browser doesn't support javascript.
loading
A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia.
Krishnan, Vaidehi; Schmidt, Florian; Nawaz, Zahid; Venkatesh, Prasanna Nori; Lee, Kian Leong; Ren, Xi; Chan, Zhu En; Yu, Mengge; Makheja, Meera; Rayan, Nirmala Arul; Lim, Michelle Gek Liang; Cheung, Alice Man Sze; Bari, Sudipto; Chng, Wee Joo; Than, Hein; Ouyang, John; Rackham, Owen; Tan, Tuan Zea; Hwang, William Ying Khee; Chuah, Charles; Prabhakar, Shyam; Ong, S Tiong.
  • Krishnan V; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Schmidt F; Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Singapore.
  • Nawaz Z; Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Singapore.
  • Venkatesh PN; Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Singapore.
  • Lee KL; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Ren X; Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Singapore.
  • Chan ZE; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Yu M; Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Makheja M; Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Singapore.
  • Rayan NA; Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Singapore.
  • Lim MGL; Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, Singapore.
  • Cheung AMS; Department of Haematology, Singapore General Hospital, Singapore.
  • Bari S; Division of Medical Sciences, National Cancer Centre, Singapore.
  • Chng WJ; Advanced Cell Therapy and Research Institute, Singapore.
  • Than H; Oncology Academic Clinical Program, Duke-NUS Medical School, Singapore.
  • Ouyang J; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Rackham O; National University Cancer Institute, National University Hospital System, Singapore.
  • Tan TZ; NUS Center for Cancer research and Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Hwang WYK; Department of Haematology, Singapore General Hospital, Singapore.
  • Chuah C; Cardiovascular & Metabolic Disorders Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Prabhakar S; Cardiovascular & Metabolic Disorders Signature Research Programme, Duke-NUS Medical School, Singapore.
  • Ong ST; School of Biological Sciences, University of Southampton, Southampton, United Kingdom.
Blood ; 141(22): 2738-2755, 2023 06 01.
Article en En | MEDLINE | ID: mdl-36857629
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article